Related Experiment Video
Updated: Jan 12, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Significance of HLA DR4 in type 1 autoimmune hepatitis
A J Czaja1, H A Carpenter, P J Santrach
1Division of Gastroenterology and Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Insights
Patients with HLA DR4, a risk factor for autoimmune hepatitis, show distinct clinical features and a better response to corticosteroids than those with HLA DR3. Subclassification by HLA may offer prognostic value.
Area of Science:
- Immunogenetics
- Hepatology
- Autoimmune Diseases
Background:
- Human Leukocyte Antigen (HLA) DR3 and DR4 are established independent risk factors for autoimmune hepatitis.
- Understanding the clinical implications of specific HLA types is crucial for managing autoimmune liver disease.
Purpose of the Study:
- To compare the clinical features and prognosis of autoimmune hepatitis patients with HLA DR4 to those with HLA DR3 and other HLA phenotypes.
- To evaluate the clinical utility of subclassification by HLA DR type in autoimmune hepatitis.
Main Methods:
- A cohort study involving 44 patients with HLA DR4, 41 with HLA DR3, and 16 with neither allele.
- Analysis of clinical characteristics, serum immunoglobulin G levels, concurrent autoimmune diseases, and response to corticosteroid therapy.
Main Results:
- Patients with HLA DR4 were older, more frequently women, and had higher immunoglobulin G levels and more concurrent autoimmune diseases compared to HLA DR3 patients.
- HLA DR4 patients demonstrated a significantly higher remission rate (85%) during corticosteroid therapy compared to HLA DR3 patients (63%).
- Treatment failure was less frequent in HLA DR4 patients (10%) than in HLA DR3 patients (32%).
Conclusions:
- Patients with HLA DR4 exhibit a distinct clinical profile and a superior response to corticosteroid treatment compared to HLA DR3 patients.
- Subclassification of autoimmune hepatitis patients based on HLA DR phenotype holds potential clinical and prognostic significance.
Background:
HLA DR3 and DR4 have been recognized as independent risk factors for autoimmune hepatitis. We compared the clinical features and prognosis of patients with HLA DR4 to those with HLA DR3 and other phenotypes to determine if subclassification by HLA is a valid consideration.
Methods:
Forty-four patients with HLA DR4; 41 patients with HLA DR3; and 16 patients with neither allele were studied. Ninety patients were treated with corticosteroids.
Results:
Patients with HLA DR4 were older (51 +/- 2 years vs. 38 +/- 3 years, P = 0.0001) and more commonly women (89% vs. 68%, P = 0.04) than counterparts with HLA DR3. Additionally, these patients had higher serum immunoglobulin G levels (3300 +/- 216 mg/dL vs. 2732 +/- 192 mg/dL, P = 0.05) and a greater frequency of concurrent immunologic diseases (59% vs. 27%, P = 0.005). Similar differences in clinical presentation distinguished the patients with HLA DR4 from those with other phenotypes. Remission during corticosteroid therapy (85% vs. 63%, P = 0.05) occurred more commonly in the patients with HLA DR4 than in those with HLA DR3 and treatment failure (10% vs. 32%, P = 0.03) occurred less frequently.
Conclusions:
Patients with HLA DR4 have a different clinical profile than counterparts with other phenotypes, and they have a better response to corticosteroid therapy than patients with HLA DR3. Subclassification of patients by HLA DR phenotype may have clinical and prognostic value.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Rh Blood Group
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

